|
MediWatch
Ltd was founded by Philip Stimpson
in 1996, to develop medical
products for the point-of-care
environment. Initially, the
Company focused on the Primary
Care market and developed a
few niche diagnostic products
for urology. In October 2000,
Mediwatch successfully listed
on the AIM with the reverse
take-over of Prostcare Plc.
Mediwatch Plc raised in excess
of £6 million for research
and a “systems approach” to
product development. In December
2006, Mediwatch Plc successfully
completed an agreement to purchase
stock and license certain intellectual
property from the urology diagnostics
division of Medtronic A/S.
This acquisition brought the
benefit of a global footprint
distribution network.
|
|
Mediwatch Plc has won four prestigious Research and Technology awards for innovation from the British and European governments. Mediwatch Plc has approvals in ISO13485, CE, CMDCAS and is compliant with FDA.
|
|
